Advertisement

Lupus Miliaris Disseminatus Faciei Pathology

Exploring the histopathological features, clinical presentation, and differential diagnosis of LMDF, a rare granulomatous facial dermatosis.

By Sneha Tete, Integrated MA, Certified Relationship Coach
Created on

Introduction

Lupus miliaris disseminatus faciei (LMDF), also known as acne agminata, is a rare chronic inflammatory dermatosis primarily affecting the face. It manifests as multiple small, reddish-brown papules and nodules, often mistaken for acne vulgaris, rosacea, or syringoma. Historically linked to tuberculosis due to its granulomatous histology, modern consensus views LMDF as a distinct entity or an extreme variant of granulomatous rosacea, unrelated to mycobacterial infection.

The condition typically arises in young adults aged 20-40, with a slight female predominance. Lesions cluster symmetrically around the central face—eyelids, cheeks, nasolabial folds, and forehead—sparing the nose and mouth. They evolve over 1-3 years, often resolving spontaneously but leaving atrophic, varioliform scars in up to 88% of cases.

LMDF’s aetiology remains idiopathic, though hypotheses include hypersensitivity to follicular contents, Demodex folliculitis, or Mycobacterium tuberculosis products triggering caseous necrosis. No infectious agent is consistently identified via PCR or culture.

Clinical Features

LMDF presents with asymptomatic or mildly pruritic monomorphic papules (1-3 mm) that may pustulate or crust upon manipulation. Lesions appear in crops, scattered or clustered, predominantly on the central face. Common sites in descending order: nasolabial folds, lower jaw, forehead, cheeks, upper jaw, and periorbital areas.

  • Duration: Average 14.8 months (range 1-120 months).
  • Symptoms: Usually none; mild itching in ~30%.
  • Evolution: Spontaneous regression in 1-3 years; atrophic scars in 88.63%.
  • Extrafacial involvement: Rare, but reported on neck, trunk, extremities.

Misdiagnoses are frequent: rosacea (14 cases), acne, hidradenoma, sarcoidosis, trichilemmal cyst. Dermoscopy aids diagnosis, revealing characteristic patterns.

Dermoscopic Features

In 44 cases, key dermoscopic findings include:

  • Orange structureless background (30/44, 68%).
  • Follicular plugs (32/44, 73%).
  • Follicular white scar-like areas (32/44, 73%).
  • Unspecific linear vessels (24/44, 55%).
  • Linear vessels with branches (24/44, 55%).
  • White streaks (18/44, 41%).
  • Follicular red dots (2/44).

No significant variations by age or gender. These features distinguish LMDF from acne (comedones) or rosacea (telangiectasia).

Histopathology

Biopsy is crucial for diagnosis, revealing superficial dermal epithelioid granulomas with or without caseation—hallmarks in 109 cases studied.

Microscopic Findings:

  • Predominant (66.97%): Epithelioid granulomas with caseous necrosis in superficial dermis; perifollicular accentuation; follicular plugs (73%); rare cornoid cysts (3.67%).
  • Epithelioid granulomas without necrosis (17.43%): Sarcoidal or tuberculoid appearance adjacent to adnexa.
  • Abscess formation (11.01%): Neutrophils, eosinophils with granulomas.
  • Mononuclear infiltrate only (4.59%): Early lesions with lymphocytes, minimal histiocytes.
  • Late stage: Perifollicular fibrosis, epidermal thinning.

Granulomas are round, well-circumscribed, with central caseation resembling tuberculosis but negative Ziehl-Neelsen (ZN) and GMS stains. Chronic lymphocytic infiltrate surrounds granulomas.

Figures Description (Conceptual)

  • Figure 1: Low-power view showing dermal granulomas around follicles.
  • Figure 2: High-power: caseating necrosis within epithelioid granuloma.
  • Figure 3: Perifollicular fibrosis in resolved lesion.
  • Figure 4: Dermoscopic orange background with follicular plugs.

Differential Diagnosis

LMDF mimics several granulomatous conditions. Key distinctions:

ConditionKey FeaturesDistinguishing Tests
SarcoidosisNaked granulomas, no caseation (fibrinoid rare)Chest X-ray, ACE levels; lacks necrosis
Granulomatous RosaceaMilder perivascular granulomas, less necrosisClinical telangiectasia; debated as LMDF variant
TB/LeprosyCaseation + AFBZN+, PCR+, culture
Syphilis/FungalPlasma cells, organismsPCR, Warthin-Starry, GMS
Acne/SyringomaComedones, ductal structuresClinical/dermoscopy

Special stains (ZN, GMS) rule out infections; PCR/culture if suspected. Granulomatous rosacea debate persists—some classify LMDF as its severe form due to overlapping histology.

Pathogenesis

Unknown, but proposed mechanisms:

  • Follicular occlusion: Leading to granulomatous response.
  • Hypersensitivity: To mycobacterial antigens or Demodex.
  • Granulomatous rosacea spectrum: Extreme perifollicular variant.
  • FIRE (Facial Idiopathic GranUlomas with Regressive Evolution): Proposed reclassification.

Stages: Early (lymphocytic), intermediate (granulomas ± necrosis), late (fibrosis).

Treatment

No RCTs; empirical. Lesions often self-resolve.

  • First-line: Oral tetracyclines (doxycycline 100mg BID, 3-6 months).
  • Alternatives: Isotretinoin, dapsone, low-dose prednisone, clofazimine.
  • Emerging: 1450-nm diode laser for scars/recalcitrant cases.
  • Topicals: Limited role; tacrolimus occasionally.

Recurrence rare post-resolution. Scars may need laser resurfacing.

Frequently Asked Questions (FAQs)

Q: Is LMDF contagious?

A: No, it is not infectious despite granulomatous histology; negative stains confirm.

Q: How long does LMDF last?

A: Typically 1-3 years with spontaneous regression, leaving scars.

Q: Can LMDF be cured?

A: It self-resolves; tetracyclines hasten improvement but no guaranteed cure.

Q: Is LMDF a form of rosacea?

A: Debated; many experts consider it a granulomatous rosacea variant.

Q: What does LMDF look like under dermoscopy?

A: Orange background, follicular plugs, white scars, branched vessels.

Conclusion

LMDF demands histopathological confirmation for its distinctive caseating granulomas amid facial papules. Early biopsy prevents misdiagnosis, guiding management toward resolution and scar minimization. Ongoing research refines its nosology within granulomatous dermatoses.

References

  1. Clinical analysis of lupus miliaris disseminatus faciei — Frontiers in Medicine. 2024. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1382526/full
  2. Lupus miliaris disseminatus faciei pathology — DermNet NZ. 2013 (updated). https://dermnetnz.org/topics/lupus-miliaris-disseminatus-faciei-pathology
  3. Lupus miliaris disseminatus faciei — Wikipedia (sourced primaries). N/A. https://en.wikipedia.org/wiki/Lupus_miliaris_disseminatus_faciei
Sneha Tete
Sneha TeteBeauty & Lifestyle Writer
Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to renewcure,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete